8-KOther EventsExhibits & Filings

BeOne Medicines Ltd. 8-K Report, Corporate Update (Mar 29, 2023)

Filed March 29, 2023For Securities:ONCBEIGF

Summary

BeiGene, Ltd. (ONC) has filed an 8-K report detailing amendments to its Independent Director Compensation Policy, effective April 1, 2023. The primary changes involve an increase in annual cash retainers for independent directors and committee service. This move aims to align compensation with market standards and potentially attract and retain experienced individuals for its Board of Directors.

Key Highlights

  • 1BeiGene, Ltd. amended its Independent Director Compensation Policy on March 27, 2023.
  • 2Effective April 1, 2023, the annual cash retainer for independent directors increases by $5,000 to $65,000.
  • 3Additional fees for committee service (member or chair) have also been increased, with specified ranges for different committee roles.
  • 4Increases for committee chairperson roles range from $2,000 to $10,000 annually.
  • 5Increases for committee member roles range from $1,000 to $5,000 annually.
  • 6There are no changes to the amount or composition of equity awards for independent directors.
  • 7The full amended policy is available as Exhibit 10.1 to the 8-K filing.

Frequently Asked Questions